Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Friday, December 23, 2022

The COVID 19, Coronavirus Outbreak in China. Moderna Valuation.

 


There are reports that around 37 million people are infected with COVID 19, coronavirus in China. A day.

It seems Chinese authorities are letting COVID run freely in China and the results are obvious.

If COVID 19 in China gets out of control the global economy will go in to a deep and prolonged recession -> something like 3 % to 5 % yearly declines in GDP for several years.

Or simply put, the coronavirus running rampant in China could trigger an economic depression.

Moderna and BiONTech will benefit immensely from the current COVID 19 outbreak in China, in my opinion.




The Chinese COVID 19, coronavirus vaccines made by Chinese companies are not deemed as effective as Moderna and BiONTech COVID 19 shots, according to many sources.

Moderna, especially, due to the fact that it is the pioneer in messengerRNA technology and producer of arguably the most effective COVID 19, coronavirus vaccines could see huge, extraordinary increases in revenue and profits and by extension of its market capitalisation.

Moderna is currently valued at circa 77 billion USD by public markets.

In my opinion, the intrinsic value of Moderna, also predicted on the current COVID 19 outbreak in China is around 300 billion USD.

MessengerRNA is the technological future of medicine and Moderna is the proven pioneer in mRNA.




No comments: